The Hang Seng Healthcare Index: Rules and Constituents42

The Hang Seng Healthcare Index (HSHCI) is a stock market index that tracks the performance of the 30 largest healthcare companies listed on the Hong Kong Stock Exchange (HKEX). The index was launched on May 27, 2019, and is calculated on a real-time basis. The HSHCI is a weighted index, which means that the companies with the largest market capitalizations have a greater impact on the index's value. The index is reviewed and rebalanced on a quarterly basis.

Criteria for Inclusion in the HSHCI

To be eligible for inclusion in the HSHCI, a company must meet the following criteria:
Be incorporated in Hong Kong
Have a primary listing on the HKEX
Have a market capitalization of at least HK$10 billion
Be classified as a healthcare company according to the Global Industry Classification Standard (GICS)

Weighting of the HSHCI

The HSHCI is a weighted index, which means that the companies with the largest market capitalizations have a greater impact on the index's value. The weighting of each company in the index is calculated as follows:```
Weight = (Market capitalization of the company / Total market capitalization of all companies in the index) * 100
```

Performance of the HSHCI

The HSHCI has performed well since its launch in 2019. The index has outperformed the Hang Seng Index, which is the benchmark index for the Hong Kong stock market. The HSHCI has also outperformed other healthcare indices, such as the MSCI AC Asia Pacific ex Japan Health Care Index.

Constituents of the HSHCI

The following are the constituents of the HSHCI as of March 31, 2023:
Ping An Healthcare and Technology Company Limited
WuXi Biologics (Cayman) Inc.
China Traditional Chinese Medicine Holdings Company Limited
JD Health International Inc.
China Resources Medical Holdings Limited
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Zai Lab Limited
China Medical System Holdings Limited
Sunshine Healthcare Holdings Limited
COFCO Healthcare Holdings Limited
Sino Biopharmaceutical Limited
CanSino Biologics Inc.
Wuxi AppTec Co., Ltd.
Yisheng Bio-Pharma Co., Ltd.
United Laboratories, Inc.
Zhejiang Medicine Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd.
Ascletis Pharma Inc.
Samsung Biologics Co., Ltd.
AstraZeneca PLC
Becton, Dickinson and Company
GlaxoSmithKline PLC
Johnson & Johnson
Medtronic PLC
Novartis AG
Pfizer Inc.
Roche Holding AG
Sanofi SA